Close Menu

NEW YORK (GenomeWeb) – OncoCyte announced on Wednesday that it has closed a $10 million private placement with two unnamed existing investors.

According to OncoCyte, the investors agreed to buy 7,936,508 shares of the company's common stock at $1.26 per share. OncoCyte said that it has already received $8 million from the stock sale and that one investor has committed to purchasing $2 million worth of additional shares before April 30.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.